Mixtard Onset and Peak Action
Mixtard 30/70 (30% regular human insulin/70% NPH insulin) begins to act within 30 minutes after subcutaneous injection, with peak action occurring between 2-8 hours post-injection.
Pharmacokinetic Profile
The biphasic action profile of Mixtard reflects its two insulin components:
Onset of Action (30 minutes)
- The regular human insulin component (30%) drives the initial onset
- Action begins approximately 30 minutes after subcutaneous administration
- This rapid-acting portion addresses immediate postprandial glucose control
Peak Effect (2-8 hours)
- Dual peak pattern due to the mixed formulation:
- First peak (2-4 hours): Primarily from the regular insulin component
- Second peak (4-8 hours): From the NPH (protamine-crystallized) component
- The protamine crystallization of the 70% NPH fraction creates the prolonged intermediate-acting effect
Duration of Action
- Total duration extends up to 24 hours, though this varies by individual factors including:
- Injection site
- Subcutaneous blood flow
- Insulin dose
- Individual patient metabolism
Clinical Application
Research demonstrates that Mixtard maintains effective glycemic control when administered twice daily 1. The formulation shows no blunting of the soluble component's action when premixed, making it as efficacious as syringe-mixed preparations 2.
Timing Considerations
- Typically administered before breakfast and dinner in a 2/3 morning, 1/3 evening split 3
- The 30-minute onset requires injection before meals to optimize postprandial glucose control
- The extended peak window (2-8 hours) provides coverage through both postprandial and interprandial periods
Important Caveats
Hypoglycemia risk: The overlapping peak effects create vulnerability windows, particularly:
- Mid-morning (2-4 hours post-breakfast dose)
- Afternoon to evening (4-8 hours post-breakfast dose)
- Overnight (if evening dose peaks during sleep)
Individual variability: Absorption rates differ based on injection site (abdomen fastest, then arms, then thighs/buttocks), making consistent injection site rotation within the same anatomical area important for predictable action.